Setting the gold standard in the supplement industry since 1999.
Niagen Bioscience began as a reference standards company. Our job was specific. We supplied laboratories, manufacturers, and regulators standardized ingredients, and they could rely on our gold standard scientific rigor. Since day one, we’ve been about purity, potency, and identity.
Twenty-five years of that work teaches you that a label is a claim, and a claim is only as good as the science behind it.
So when we eventually put our own supplement on the shelf, we knew exactly what we'd be asking you to trust. We decided to earn it the long way: our own clinical research, published under our own name, and a certificate of analysis you can pull up for the specific lot in your hand.
“Many people sell NAD+ products. We invent them.” - Philip Redpath, Director, R&D at Niagen Bioscience
ChromaDex, Inc., a subsidiary of Niagen Bioscience, Inc. is founded with a bold mission: to bring cutting-edge science to the world. Collaborating with top universities and institutions, we set the stage for life-changing health innovations.
We begin licensing groundbreaking ingredient
technologies. This pivotal moment drives our ambition to
unlock new possibilities in human health through science.
ChromaDex, Inc., a subsidiary of Niagen Bioscience, Inc. makes waves with Niagen, a patented form of Nicotinamide Riboside (NR). This revolutionary discovery redefines cellular health and aging, bringing us closer to healthier lives.
With Tru Niagen, our vision becomes reality. Consumers around the world can now support their cellular health through this innovative product, marking a new era for ChromaDex, Inc., a subsidiary of Niagen Bioscience, Inc.
Tru Niagen expands internationally, cementing ChromaDex, Inc., a subsidiary of Niagen Bioscience, Inc. as a leader in health and wellness. Our evidence-based approach earns global recognition and trust.
Tru Niagen sets the industry standard for safety, quality, and transparency. Backed by two Nobel Prize winners, 45+ clinical trials, and 500+ studies, it’s recognized by leading regulatory authorities. And we’re just getting started—Niagen Bioscience is committed to driving the future of health through innovation.
Dr. Charles Brenner
Chair of the Department of Diabetes and Cancer Metabolism, City of Hope
World's foremost authority on NAD+ metabolism
Dr. Vilhelm (Will) Bohr, M.D., Ph.D., D.Sc.
Chief of the Laboratory of Molecular Genetics at the National Institute on Aging
One of the world’s most published researchers on aging and neurodegenerative disease
Dr. Roger Kornberg
Professor of Structural Biology, Stanford University School of Medicine
Nobel Prize Winner, Chemistry
Dr. Rudolph Tanzi
Kennedy Professor of Neurology, Harvard University
Director, Genetics and Aging Research Unit, Massachusetts General Hospital
Dr. Brunie H. Felding
Associate Professor of Molecular Medicine, Scripps Research Institute
Renowned breast cancer researcher focused on NAD+ supplementation
Dr. Bruce German
Chairman of Food, Nutrition, and Health, University of California, Davis
Distinguished researcher in nutrition research and milk science
Dr. Pinchas Hassy Cohen
Dean, USC Leonard Davis School of Gerontology
Pioneering researcher in mitochondrial microproteins and gerontology
Our lab. Our standards.
We value and encourage strong scientific rigor and evidence behind our claims. We have a dedicated state-of-the-art research and development facility in Longmont, Colorado. Our science is global with more than 300 research collaborations through the Niagen Research Program, a division of Niagen Bioscience.